Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
about
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.SLFN11 Blocks Stressed Replication Forks Independently of ATR.Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.[Recent Advances and Future Strategies for Small Cell Lung Cancer].Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models.
P2860
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@ast
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@en
type
label
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@ast
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@en
prefLabel
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@ast
Dynamic variations in epitheli ...... tin in small cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Dynamic variations in epitheli ...... atin in small cell lung cancer
@en
P2093
Bonnie S Glisson
C Allison Stewart
Carl M Gay
Don L Gibbons
Fatemah Masrorpour
Ignacio Wistuba
Junya Fujimoto
Lauren Averett Byers
P2860
P304
28575-28587
P356
10.18632/ONCOTARGET.15338
P407
P577
2017-04-01T00:00:00Z